Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Cash from Investing Activities: 2011-2024

Historic Cash from Investing Activities for Abeona Therapeutics (ABEO) over the last 13 years, with Dec 2024 value amounting to -$39.2 million.

  • Abeona Therapeutics' Cash from Investing Activities fell 947.95% to -$64.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $114.3 million, marking a year-over-year increase of 345.45%. This contributed to the annual value of -$39.2 million for FY2024, which is 18965.38% down from last year.
  • According to the latest figures from FY2024, Abeona Therapeutics' Cash from Investing Activities is -$39.2 million, which was down 18,965.38% from $208,000 recorded in FY2023.
  • Abeona Therapeutics' Cash from Investing Activities' 5-year high stood at $66.1 million during FY2021, with a 5-year trough of -$83.7 million in FY2020.
  • Over the past 3 years, Abeona Therapeutics' median Cash from Investing Activities value was -$24.0 million (recorded in 2022), while the average stood at -$21.0 million.
  • Per our database at Business Quant, Abeona Therapeutics' Cash from Investing Activities surged by 178.91% in 2021 and then tumbled by 18,965.38% in 2024.
  • Over the past 5 years, Abeona Therapeutics' Cash from Investing Activities (Yearly) stood at -$83.7 million in 2020, then soared by 178.91% to $66.1 million in 2021, then plummeted by 136.28% to -$24.0 million in 2022, then soared by 100.87% to $208,000 in 2023, then crashed by 18,965.38% to -$39.2 million in 2024.